Christoph Schneider

University of Zurich
Country flagSwitzerland

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

The salivary glands often become damaged in individuals receiving radiotherapy for head and neck cancer, resulting in chronic dry mouth. This leads to detrimental effects on their health and quality of life, for which there is no regenerative therapy. Macrophages are the predominant immune cell in the salivary glands and are attractive therapeutic targets due to their unrivaled capacity to drive tissue repair. Yet, the nature and role of macrophages in salivary gland homeostasis and how they may contribute to tissue repair after injury are not well understood. Here, we show that at least two phenotypically and transcriptionally distinct CX3CR1 + macrophage populations are present in the adult salivary gland, which occupy anatomically distinct niches. CD11c + CD206 – CD163 – macrophages typically associate with gland epithelium, whereas CD11c − CD206 + CD163 + macrophages associate with blood vessels and nerves. Using a suite of complementary fate mapping systems, we show that there are highly dynamic changes in the ontogeny and composition of salivary gland macrophages with age. Using an in vivo model of radiation-induced salivary gland injury combined with genetic or antibody-mediated depletion of macrophages, we demonstrate an essential role for macrophages in clearance of cells with DNA damage. Furthermore, we show that epithelial-associated macrophages are indispensable for effective tissue repair and gland function after radiation-induced injury, with their depletion resulting in reduced saliva production. Our data, therefore, provide a strong case for exploring the therapeutic potential of manipulating macrophages to promote tissue repair and thus minimize salivary gland dysfunction after radiotherapy.

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (23)

Christoph Messner

Assistant Professor for Precision Proteomics

University of Zurich

SWITZERLAND
View details

Yasutaka Mitamura

-

SWITZERLAND
View details

Gareth-Rhys Jones

Clinical Lecturer

-

UNITED KINGDOM
View details

Isabelle C. Arnold

Assistant Professor

University of Zurich

SWITZERLAND
View details

Ari Molofsky

Associate Professor

University of California, San Francisco

UNITED STATES
View details

Manfred Kopf

Professor

ETH Zürich

SWITZERLAND
View details

Elaine Emmerson

University of Edinburgh

UNITED KINGDOM
View details

David Legouis

University of Geneva

SWITZERLAND
View details

Julien Guiot

Associate Professor & Principal Investigator

University of Liege

BELGIUM
View details

Carsten C. Scholz

University of Zurich

SWITZERLAND
View details

Xiaogang Feng

Karolinska Institutet

SWEDEN
View details

Alex Clarke

University of Oxford

UNITED KINGDOM
View details

Basak Corak

University of Zurich

SWITZERLAND
View details

Arthur Mortha

University of Toronto

CANADA
View details

Hubert Rehrauer

-

SWITZERLAND
View details

Claire O'Leary

Assistant Professor

University of Wisconsin-Madison

UNITED STATES
View details

Jesmond Dalli

Professor in Molecular Pharmacology, Sir Henry Dale Fellow, Lipid Mediator Unit Director

William Harvey Research Institute

UNITED KINGDOM
View details

Emma Slack

Professor at ETH Zürich

ETH Zürich

SWITZERLAND
View details

Andrew M. Hall

University of Zurich

SWITZERLAND
View details

Richard M. Locksley

University of California

UNITED STATES
View details

Masatoshi Kanda

Lecturer

Sapporo Medical University

JAPAN
View details

Burkhard Becher

University of Zurich

SWITZERLAND
View details

Stellor Nlandu Khodo

Senior scientist/Head of Ambizione group

University of Zurich

SWITZERLAND
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.